These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1957 related items for PubMed ID: 8765197

  • 1. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F, Farao M, Ciomei M, Pastori A, Mongelli N, Grandi M.
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK, Halsør EF.
    Cancer Res; 2000 Sep 01; 60(17):4932-8. PubMed ID: 10987309
    [Abstract] [Full Text] [Related]

  • 4. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 01; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB.
    Cancer Res; 1996 Dec 01; 56(23):5319-24. PubMed ID: 8968076
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of lung and liver tumor colonies in mice pretreated with suramin.
    Sola F, Farao M, Marsiglio A, Mariani M, Grandi M.
    Invasion Metastasis; 1993 Dec 01; 13(3):163-8. PubMed ID: 8112976
    [Abstract] [Full Text] [Related]

  • 7. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rösel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F.
    Cancer Res; 2000 Apr 15; 60(8):2178-89. PubMed ID: 10786682
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM.
    Cancer; 2000 Aug 01; 89(3):488-99. PubMed ID: 10931447
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of FCE 26644 a new growth-factor complexing molecule.
    Sola F, Farao M, Pesenti E, Marsiglio A, Mongelli N, Grandi M.
    Cancer Chemother Pharmacol; 1995 Aug 01; 36(3):217-22. PubMed ID: 7781141
    [Abstract] [Full Text] [Related]

  • 10. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
    Hidvégi M, Ráso E, Tömösközi-Farkas R, Paku S, Lapis K, Szende B.
    Anticancer Res; 1998 Aug 01; 18(4A):2353-8. PubMed ID: 9703878
    [Abstract] [Full Text] [Related]

  • 11. Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.
    Pavco PA, Bouhana KS, Gallegos AM, Agrawal A, Blanchard KS, Grimm SL, Jensen KL, Andrews LE, Wincott FE, Pitot PA, Tressler RJ, Cushman C, Reynolds MA, Parry TJ.
    Clin Cancer Res; 2000 May 01; 6(5):2094-103. PubMed ID: 10815937
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM.
    Medicina (B Aires); 2000 May 01; 60 Suppl 2():41-7. PubMed ID: 11188930
    [Abstract] [Full Text] [Related]

  • 13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 15; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 15. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
    Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TA, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, Cherrington.
    Cancer Res; 2000 Aug 01; 60(15):4152-60. PubMed ID: 10945623
    [Abstract] [Full Text] [Related]

  • 16. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
    Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, Friedman SL, Vidal-Vanaclocha F.
    Hepatology; 2003 Mar 01; 37(3):674-85. PubMed ID: 12601365
    [Abstract] [Full Text] [Related]

  • 17. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor.
    Funahashi Y, Wakabayashi T, Semba T, Sonoda J, Kitoh K, Yoshimatsu K.
    Oncol Res; 1999 Mar 01; 11(7):319-29. PubMed ID: 10757446
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.
    Rofstad EK, Danielsen T.
    Br J Cancer; 1999 Aug 01; 80(11):1697-707. PubMed ID: 10468285
    [Abstract] [Full Text] [Related]

  • 19. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
    Takayama K, Ueno H, Nakanishi Y, Sakamoto T, Inoue K, Shimizu K, Oohashi H, Hara N.
    Cancer Res; 2000 Apr 15; 60(8):2169-77. PubMed ID: 10786681
    [Abstract] [Full Text] [Related]

  • 20. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions.
    Piantelli M, Rossi C, Iezzi M, La Sorda R, Iacobelli S, Alberti S, Natali PG.
    J Cell Physiol; 2006 Apr 15; 207(1):23-9. PubMed ID: 16222712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 98.